# Prestige Consumer Healthcare (PBH) — Earnings

PBH · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/pbh/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q1 2027 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.98 |
| EPS estimate | $0.88 |
| EPS surprise | +11.19% |
| Revenue surprise | +6.14% |
| Revenue | $265.7M |
| Revenue estimate | $250.3M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1295947/000129594726000042/pbh-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/49055f90-760e-a448-1bdd-233d101c4292.html) |

Prestige Consumer Healthcare reported fiscal Q1 2027 results on August 6, 2026. Earnings per share were $0.98, ahead of the $0.88 estimate by 11.19%. Revenue of $265.7 million beat the $250.3 million consensus by 6.14%. Compared with fiscal Q1 2026, EPS rose about 3% from $0.95 and revenue rose about 6.5% from $249.5 million.

The longer record is steady. Annual EPS was $4.22 in fiscal 2023, $4.21 in fiscal 2024, $4.53 in fiscal 2025 and $4.39 in fiscal 2026, about 3% lower than the year before. Annual revenue stayed between $1.13 billion and $1.14 billion from fiscal 2023 to 2025, then eased about 4% to $1.09 billion in fiscal 2026. In fiscal 2025 and 2026, Q1 was the lowest-earning quarter and Q4 the highest. Fiscal Q4 2025 set the highs in the table at $1.32 per share and $296.5 million. Prestige beat the EPS estimate in 16 of the last 20 quarters, and twice in the last four.

Fiscal Q2 results came between November 2 and November 7 in each of the past five years. That points to early November 2026 for the next report. It will show whether the year-over-year gain in revenue continues.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q1 2027 | Aug 6, 2026 | $0.88 | $0.98 | 11.19% | $250.3M | $265.7M |
| Q4 2026 | May 13, 2026 | $1.39 | $1.23 | -11.51% | $293.6M | $281.6M |
| Q3 2026 | Feb 5, 2026 | $1.14 | $1.14 | -0.39% | $282.0M | $283.4M |
| Q2 2026 | Nov 6, 2025 | $0.97 | $1.07 | 10.35% | $257.0M | $274.1M |
| Q1 2026 | Aug 7, 2025 | $1.00 | $0.95 | -4.99% | $260.8M | $249.5M |
| Q4 2025 | May 8, 2025 | $1.30 | $1.32 | 1.66% | $289.6M | $296.5M |
| Q3 2025 | Feb 6, 2025 | $1.18 | $1.22 | 3.82% | $287.8M | $290.3M |
| Q2 2025 | Nov 7, 2024 | $1.08 | $1.09 | 0.50% | $282.1M | $283.8M |
| Q1 2025 | Aug 8, 2024 | $0.86 | $0.90 | 4.72% | $260.4M | $267.1M |
| Q4 2024 | May 14, 2024 | $1.14 | $1.02 | -10.46% | $287.4M | $277.0M |
| Q3 2024 | Feb 8, 2024 | $1.04 | $1.06 | 1.83% | $280.2M | $282.7M |
| Q2 2024 | Nov 2, 2023 | $1.07 | $1.07 | 0.25% | $285.2M | $286.3M |
| Q1 2024 | Aug 3, 2023 | $1.01 | $1.06 | 5.01% | $278.8M | $279.3M |
| Q4 2023 | May 4, 2023 | $1.04 | $1.07 | 2.90% | $278.9M | $285.9M |
| Q3 2023 | Feb 2, 2023 | $1.01 | $1.04 | 2.77% | $273.8M | $275.5M |
| Q2 2023 | Nov 3, 2022 | $1.00 | $1.02 | 1.83% | $283.2M | $289.3M |
| Q1 2023 | Aug 4, 2022 | $1.04 | $1.09 | 4.98% | $268.9M | $277.1M |
| Q4 2022 | May 5, 2022 | $0.89 | $0.91 | 2.63% | $258.3M | $266.9M |
| Q3 2022 | Feb 3, 2022 | $0.88 | $0.99 | 12.08% | $260.4M | $274.5M |
| Q2 2022 | Nov 4, 2021 | $0.99 | $1.02 | 3.37% | $261.2M | $276.2M |

## Frequently Asked Questions

### When did Prestige Consumer Healthcare (PBH) last report earnings?

Prestige Consumer Healthcare last reported on Aug 6, 2026, covering fiscal Q1 2027.

### Did PBH beat earnings estimates?

Yes. Prestige Consumer Healthcare reported EPS of $0.98 for Q1 2027 against a $0.88 estimate — a 11.19% beat.

### How much revenue did PBH report last quarter?

Prestige Consumer Healthcare reported $265.7M in revenue for Q1 2027, against a consensus estimate of $250.3M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).